Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have developed a new vaccine platform designed to offer stronger, longer-lasting protection against both COVID-19 and influenza while providing broader immunity against various flu strains. A study published in Science Advances found […]
Source link